What is the analyst consensus rating for RVMD?

The analyst consensus rating for RVMD is "Strong Buy" based on 12 analyst recommendations.

What is the average price target for RVMD?

The average 12-month price target for RVMD is $168.08, representing an upside of 11.8% from the current price of $150.33.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Revolution Medicines, Inc. (RVMD) Forecast: Analyst Ratings & Targets

Latest RVMD Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Apr 22, 2026	Robert Burns	HC Wainwright	Reiterates	Strong Buy	$169.00 → $169.00 +0.00 (0.0%)
Apr 22, 2026	Jonathan Chang	Leerink Partners	Maintains	Buy	$147.00 → $171.00 +24.00 (16.3%)
Apr 20, 2026	Laura Prendergast	Stifel	Reiterates	Strong Buy	$170.00 → $215.00 +45.00 (26.5%)
Apr 20, 2026	Ami Fadia	Needham	Maintains	Strong Buy	$145.00 → $186.00 +41.00 (28.3%)
Apr 14, 2026	Robert Driscoll	Wedbush	Reiterates	Buy	$147.00 → $147.00 +0.00 (0.0%)
Apr 14, 2026	Michael Schmidt	Guggenheim	Maintains	Strong Buy	$160.00 → $175.00 +15.00 (9.4%)
Apr 14, 2026	Robert Burns	HC Wainwright	Maintains	Strong Buy	$73.00 → $169.00 +96.00 (131.5%)
Apr 14, 2026	Eva Fortea Verdejo	Wells Fargo	Maintains	Buy	$144.00 → $167.00 +23.00 (16.0%)
Apr 14, 2026	Leonid Timashev	RBC Capital	Maintains	Buy	$140.00 → $162.00 +22.00 (15.7%)
Apr 14, 2026	Cory Kasimov	Evercore ISI Group	Maintains	Buy	$140.00 → $200.00 +60.00 (42.9%)
Apr 13, 2026	Jonathan Chang	Leerink Partners	Maintains	Buy	$115.00 → $147.00 +32.00 (27.8%)
Apr 13, 2026	Jay Olson	Oppenheimer	Maintains	Buy	$150.00 → $165.00 +15.00 (10.0%)
Mar 16, 2026	Clara Dong	Jefferies	Initiates	Strong Buy	$88.00 → $140.00 +52.00 (59.1%)
Feb 26, 2026	Kelsey Goodwin	Piper Sandler	Maintains	Buy	$75.00 → $120.00 +45.00 (60.0%)
Feb 26, 2026	Eva Fortea Verdejo	Wells Fargo	Maintains	Buy	$100.00 → $144.00 +44.00 (44.0%)
Feb 26, 2026	Ami Fadia	Needham	Maintains	Strong Buy	$150.00 → $145.00 -5.00 (-3.3%)

Robert Burns

HC Wainwright

Strong BuyReiterates

$169.00 → $169.00

Apr 22

Jonathan Chang

Leerink Partners

BuyMaintains

$147.00 → $171.00

Apr 22

Laura Prendergast

Stifel

Strong BuyReiterates

$170.00 → $215.00

Apr 20

Ami Fadia

Needham

Strong BuyMaintains

$145.00 → $186.00

Apr 20

Robert Driscoll

Wedbush

BuyReiterates

$147.00 → $147.00

Apr 14

Michael Schmidt

Guggenheim

Strong BuyMaintains

$160.00 → $175.00

Apr 14

Robert Burns

HC Wainwright

Strong BuyMaintains

$73.00 → $169.00

Apr 14

Eva Fortea Verdejo

Wells Fargo

BuyMaintains

$144.00 → $167.00

Apr 14

Leonid Timashev

RBC Capital

BuyMaintains

$140.00 → $162.00

Apr 14

Cory Kasimov

Evercore ISI Group

BuyMaintains

$140.00 → $200.00

Apr 14

Jonathan Chang

Leerink Partners

BuyMaintains

$115.00 → $147.00

Apr 13

Jay Olson

Oppenheimer

BuyMaintains

$150.00 → $165.00

Apr 13

Clara Dong

Jefferies

Strong BuyInitiates

$88.00 → $140.00

Mar 16

Kelsey Goodwin

Piper Sandler

BuyMaintains

$75.00 → $120.00

Feb 26

Eva Fortea Verdejo

Wells Fargo

BuyMaintains

$100.00 → $144.00

Feb 26

Ami Fadia

Needham

Strong BuyMaintains

$150.00 → $145.00

Feb 26

Revolution Medicines, Inc. (RVMD) Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest RVMD Analyst Ratings & Recommendations

Frequently Asked Questions